- Home
- Industry Reports
- Healthcare
- Medical Devices
- Europe Artificial Organs and Bionics Market – Size, Outlook, Trends and Forecast (2020 – 2026)
Artificial organs and bionics are manufactured devices that can be embedded or integrated into humans to either replace a natural organ or offer support to repair specific function, helping the patient return back to healthy living.
Europe Artificial Organ and Bionics Market Size and Growth:
Europe artificial organ and bionics market reaches nearly $XX billion by 2025 at a CAGR of 11.42% during the forecast period 2019-2025. Rising number of organ failures and disabilities, increasing technological advancements, and increasing of road accidents are bolstering the artificial organs and bionics market growth. Increasing number of device malfunctions and lack of skilled professionals are hindering the market growth.
Europe Artificial Organ and Bionics Market Segments Share:
Europe artificial organs and bionics market is segmented by a product such as an artificial organ and bionics. An artificial kidney, artificial heart and artificial liver are considered under the artificial organ. Vision bionics, orthopaedic bionics, cardiac bionics and brain bionics are considered under the bionics. By technology, the electronic bionics is an electronic device which is used in various applications such as defence sector in exoskeleton suits which helps the soldier to carry heavy loads in the battlefield which are likely to have a high emerging growth in the artificial organ and bionics market.
By Geography, Germany occupied the lion’s share in the European artificial organs and bionics market. Dominant share is accredited due to the vast technological advancements and increasing number of organ failures and injuries. U.K. is the second primary market in Europe artificial organ and bionics market.
Europe Artificial Organ and Bionics Market Segments trends:
- In February 2018, Jikei University of medicine made an agreement with Asahi Kasei Corporation for an abdominal aortic aneurysm stent development.
- In January 2018, Boston scientific received and FDA approved for spectra wave writer, spinal cord stimulator system.
Europe Artificial Organ and Bionics Market Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year-on-year
Identifying DROC in the current market and their impact on altering market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Edward Lifesciences.
- Medtronic
- LifeNet Health Inc.
- Otto Bock Healthcare GmbH.
- Esko Bionics
- Hoffman La Roche Ltd
Along with these companies, there were many other companies considered in the report while analysing the Europe artificial organs and bionics market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Rising number of organ failures and disabilities
4.1.2. Increasing technological advancement.
4.1.3. Increasing of road accidents which lead to the amputations.
4.2 Restraints & Challenges
4.2.1. Lack of skilled professional
4.2.2. Increasing number of device malfunctions.
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. Europe Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. Europe Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. Europe Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defense
8. Europe Artificial Organs and Bionics Market – By Geography
8.1 Introduction
8.3 Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
9. Europe Artificial Organs and Bionics Market – Company Profiles
9.1. Abiomed Inc.
9.2. Asahi Kasei Medical co. ltd
9.3. Baxter International Inc.
9.4. Boston Scientific Corporation.
9.5. Berlin Heart GmbH.
9.6. Cochlear limited.
9.7. Cyberonics Inc.
9.8. Edward Lifesciences.
9.9. Medtronic plc
9.10. LifeNet Health Inc.
9.11. Otto Bock Healthcare GmbH.
9.12. Esko Bionics
9.13. F. Hoffman La Roche Ltd
9.14. World Health Corporation
10. Europe Artificial Organs and Bionics Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,028.74 - €6,762.47
- INR: ₹179,132.71 - ₹597,109.04
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,760.85 - £5,869.48
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Artificial organs and bionics are manufactured devices that can be embedded or integrated into humans to either replace a natural organ or offer support to repair specific function, helping the patient return back to healthy living.
Europe Artificial Organ and Bionics Market Size and Growth:
Europe artificial organ and bionics market reaches nearly $XX billion by 2025 at a CAGR of 11.42% during the forecast period 2019-2025. Rising number of organ failures and disabilities, increasing technological advancements, and increasing of road accidents are bolstering the artificial organs and bionics market growth. Increasing number of device malfunctions and lack of skilled professionals are hindering the market growth.
Europe Artificial Organ and Bionics Market Segments Share:
Europe artificial organs and bionics market is segmented by a product such as an artificial organ and bionics. An artificial kidney, artificial heart and artificial liver are considered under the artificial organ. Vision bionics, orthopaedic bionics, cardiac bionics and brain bionics are considered under the bionics. By technology, the electronic bionics is an electronic device which is used in various applications such as defence sector in exoskeleton suits which helps the soldier to carry heavy loads in the battlefield which are likely to have a high emerging growth in the artificial organ and bionics market.
By Geography, Germany occupied the lion’s share in the European artificial organs and bionics market. Dominant share is accredited due to the vast technological advancements and increasing number of organ failures and injuries. U.K. is the second primary market in Europe artificial organ and bionics market.
Europe Artificial Organ and Bionics Market Segments trends:
- In February 2018, Jikei University of medicine made an agreement with Asahi Kasei Corporation for an abdominal aortic aneurysm stent development.
- In January 2018, Boston scientific received and FDA approved for spectra wave writer, spinal cord stimulator system.
Europe Artificial Organ and Bionics Market Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year-on-year
Identifying DROC in the current market and their impact on altering market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Edward Lifesciences.
- Medtronic
- LifeNet Health Inc.
- Otto Bock Healthcare GmbH.
- Esko Bionics
- Hoffman La Roche Ltd
Along with these companies, there were many other companies considered in the report while analysing the Europe artificial organs and bionics market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Rising number of organ failures and disabilities
4.1.2. Increasing technological advancement.
4.1.3. Increasing of road accidents which lead to the amputations.
4.2 Restraints & Challenges
4.2.1. Lack of skilled professional
4.2.2. Increasing number of device malfunctions.
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. Europe Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. Europe Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. Europe Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defense
8. Europe Artificial Organs and Bionics Market – By Geography
8.1 Introduction
8.3 Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
9. Europe Artificial Organs and Bionics Market – Company Profiles
9.1. Abiomed Inc.
9.2. Asahi Kasei Medical co. ltd
9.3. Baxter International Inc.
9.4. Boston Scientific Corporation.
9.5. Berlin Heart GmbH.
9.6. Cochlear limited.
9.7. Cyberonics Inc.
9.8. Edward Lifesciences.
9.9. Medtronic plc
9.10. LifeNet Health Inc.
9.11. Otto Bock Healthcare GmbH.
9.12. Esko Bionics
9.13. F. Hoffman La Roche Ltd
9.14. World Health Corporation
10. Europe Artificial Organs and Bionics Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.